Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

BMI over 30 is considered obese. But those having excess fat may not have a BMI 30, which shows under-diagnosis of people and ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

As weight-loss drugs like Ozempic become normalized solutions to over-eating habits, researchers at Pennington Biomedical ...

Fifteen new drugs including the Ozempic will be included in Medicare's next round of price negotiation with drug makers, the Biden administration announced Friday. Ozempic, used to treat Type 2 ...